Bio-Techne releases new T-cell activation kit

By The Science Advisory Board staff writers

May 11, 2020 -- Bio-Techne has released a new kit for cell and gene therapy manufacturing called GMP Cloudz Human T Cell Activation.

The kit is the first in the company's Cloudz product line. It contains Cloudz particles, which are dissolvable microspheres designed for CD3 and CD28 antibodies for the expansion of T cells, the company said. The kit works within the company's T cell culture platform. The particles can be added to CD3+ T cells or peripheral blood mononuclear cells (PBMC), according to Bio-Techne.

Joint venture targets cell and gene therapy
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint...
Overlooked benefits of using polyclonal antibodies
The benefits of polyclonal antibodies as tools for assay-specific target discovery and detection are numerous. As the future of basic research, diagnostics...

Copyright © 2020 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter